Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Leaflets: Merck, Pfizer Want FDA To Encourage Use Of Manufacturer Info

Executive Summary

FDA should take steps to encourage greater reliance on industry-generated patient education materials, Pfizer and Merck told the agency in comments on the "usefulness" of pharmacy leaflets

You may also be interested in...



Novartis To Assess Zelnorm “Medguide” Distribution In Phase IV Study

Novartis will create a protocol to assess the distribution of the Zelnorm "Medguide" to patients as one Phase IV commitment following FDA approval of a chronic idiopathic constipation indication

Novartis To Assess Zelnorm “Medguide” Distribution In Phase IV Study

Novartis will create a protocol to assess the distribution of the Zelnorm "Medguide" to patients as one Phase IV commitment following FDA approval of a chronic idiopathic constipation indication

Drug Labels Should Use Clearer Language, IoM Report Recommends

Drug labels should be more transparent to help patients understand the information, the Institute of Medicine suggested in a report on health literacy

Related Content

UsernamePublicRestriction

Register

PS042713

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel